Our global team of researchers and scientists harness cutting-edge science to push the boundaries of what is possible. We cultivate external collaborations and strong research capabilities to bring life-changing therapies to patients worldwide.
Takeda focuses its R&D efforts on four core therapeutic areas: Oncology, Rare Genetic and Hematology, Neuroscience and Gastroenterology, with targeted investments in Plasma-Derived Therapies and Vaccines. We are focusing on targeted patient populations in areas of high unmet need, where there is potential for greater therapeutic benefit.
We are advancing a modality-diverse pipeline with an increased focus on immuno-oncology and rare diseases. Leveraging platform capabilities in cell therapy, gene therapy and data sciences, we’re working to deliver a steady stream of next-generation therapies with transformative or curative potential across our core areas.